Skip to main content

Loose Christopher R.'s Form 4 filing

Korro Bio, Inc. (KRRO) · filed Jul 7, 2022

Accession no.
0001127602-22-019051
Filed
Jul 7, 2022
Trade date
Jul 5-6, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.75K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Loose Christopher R.CIK 0001785299Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 5, 2022Common StockMOption exerciseAcquired+15,000–F1–54,465Direct
Jul 6, 2022Common StockSSaleDisposed−4,415$1.53F4−$6,754.9550,050Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 5, 2022Common StockMOption exerciseDisposed−15,000–F1–0Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.

F4

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.49 to $1.56. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)